Human medicines European public assessment report (EPAR): Exparel liposomal, bupivacaine, Date of authorisation: 16/11/2020, Revision: 2, Status: Authorised | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 13 August 2025 - 14:41

Human medicines European public assessment report (EPAR): Exparel liposomal, bupivacaine, Date of authorisation: 16/11/2020, Revision: 2, Status: Authorised

Link:

https://www.ema.europa.eu/en/medicines/human/EPAR/exparel-liposomal

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters